Stephen Macfarlane

3.1k total citations
41 papers, 557 citations indexed

About

Stephen Macfarlane is a scholar working on Psychiatry and Mental health, General Health Professions and Clinical Psychology. According to data from OpenAlex, Stephen Macfarlane has authored 41 papers receiving a total of 557 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Psychiatry and Mental health, 12 papers in General Health Professions and 11 papers in Clinical Psychology. Recurrent topics in Stephen Macfarlane's work include Dementia and Cognitive Impairment Research (12 papers), Schizophrenia research and treatment (11 papers) and Geriatric Care and Nursing Homes (6 papers). Stephen Macfarlane is often cited by papers focused on Dementia and Cognitive Impairment Research (12 papers), Schizophrenia research and treatment (11 papers) and Geriatric Care and Nursing Homes (6 papers). Stephen Macfarlane collaborates with scholars based in Australia, United Kingdom and New Zealand. Stephen Macfarlane's co-authors include Colm Cunningham, Mustafa Atee, Daniel O’Connor, Maree Mastwyk, Craig Ritchie, Dennis Velakoulis, Susy Harrigan, Lucy Vivash, Terence J. O’Brien and Charles B. Malpas and has published in prestigious journals such as Age and Ageing, Journal of Alzheimer s Disease and Journal of Pain and Symptom Management.

In The Last Decade

Stephen Macfarlane

38 papers receiving 539 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stephen Macfarlane Australia 12 226 131 98 87 80 41 557
Terry Stedman Australia 17 286 1.3× 133 1.0× 169 1.7× 67 0.8× 133 1.7× 56 756
Lana Dixon United Kingdom 16 294 1.3× 160 1.2× 172 1.8× 70 0.8× 111 1.4× 46 1.1k
Bryan Shapiro United States 12 106 0.5× 139 1.1× 112 1.1× 51 0.6× 40 0.5× 25 733
Mary Ganguli United States 11 386 1.7× 280 2.1× 39 0.4× 54 0.6× 99 1.2× 17 787
Patricia A. Marken United States 13 273 1.2× 88 0.7× 43 0.4× 84 1.0× 76 0.9× 27 656
Maddalena La Montagna Italy 11 117 0.5× 217 1.7× 49 0.5× 57 0.7× 36 0.5× 31 605
Ross Penninkilampi Australia 8 189 0.8× 135 1.0× 49 0.5× 45 0.5× 90 1.1× 10 642
Geetha Ramaswamy United States 3 207 0.9× 262 2.0× 40 0.4× 91 1.0× 58 0.7× 6 636
Loretta Piccenna Australia 16 167 0.7× 102 0.8× 31 0.3× 108 1.2× 49 0.6× 30 707
Shaw-Ji Chen Taiwan 16 174 0.8× 109 0.8× 67 0.7× 64 0.7× 51 0.6× 43 816

Countries citing papers authored by Stephen Macfarlane

Since Specialization
Citations

This map shows the geographic impact of Stephen Macfarlane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen Macfarlane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen Macfarlane more than expected).

Fields of papers citing papers by Stephen Macfarlane

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen Macfarlane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen Macfarlane. The network helps show where Stephen Macfarlane may publish in the future.

Co-authorship network of co-authors of Stephen Macfarlane

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen Macfarlane. A scholar is included among the top collaborators of Stephen Macfarlane based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen Macfarlane. Stephen Macfarlane is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Lovell, Melanie, et al.. (2023). Dying with behavioral and psychological symptoms of dementia in Australian nursing homes: a retrospective case-control study. Frontiers in Psychiatry. 14. 1091771–1091771. 3 indexed citations
3.
Atee, Mustafa, et al.. (2021). 421 - Prevalence of Pain in Dementia Subtypes: Data from a National Sample of Aged Care Residents in Australia. International Psychogeriatrics. 33. 43–43. 1 indexed citations
4.
Macfarlane, Stephen, et al.. (2021). Evaluating the Clinical Impact of National Dementia Behaviour Support Programs on Neuropsychiatric Outcomes in Australia. Frontiers in Psychiatry. 12. 652254–652254. 18 indexed citations
5.
Macfarlane, Stephen & Colm Cunningham. (2021). Limiting antipsychotic drugs in dementia. Australian Prescriber. 44(1). 8–11. 6 indexed citations
6.
Atee, Mustafa, et al.. (2020). Pain in Dementia: Prevalence and Association With Neuropsychiatric Behaviors. Journal of Pain and Symptom Management. 61(6). 1215–1226. 53 indexed citations
7.
O’Connor, Daniel, et al.. (2017). Quality indicators of psychotropic prescribing to people with dementia in aged psychiatry inpatient units. Aging & Mental Health. 22(11). 1432–1437. 3 indexed citations
8.
Macfarlane, Stephen & Daniel O’Connor. (2016). Managing behavioural and psychological symptoms in dementia. Australian Prescriber. 39(4). 123–125. 19 indexed citations
9.
Macfarlane, Stephen, et al.. (2015). The Clinical and Service Outcomes of Unilateral and Bilateral ECT Electrode Placements in Australian Aged Psychiatry Services. Journal of Ect. 32(1). 44–48. 4 indexed citations
10.
Lewis, Matthew, et al.. (2015). Efficacy and safety of once-monthly paliperidone palmitate long-acting injection in an elderly patient with schizophrenia. BMJ Case Reports. 2015. bcr2015212149–bcr2015212149. 1 indexed citations
11.
Lewis, Matthew, et al.. (2014). Neuropsychological characteristics of people living in squalor. International Psychogeriatrics. 26(5). 837–844. 11 indexed citations
12.
Lau, Rosalind, Carol Morse, & Stephen Macfarlane. (2010). Psychological Factors Among Elderly Women With Suicidal Intentions or Attempts to Suicide: A Controlled Comparison. Journal of Women & Aging. 22(1). 3–14. 26 indexed citations
13.
Ritchie, Craig, et al.. (2009). Predictors of adherence to atypical antipsychotics (risperidone or olanzapine) in older patients with schizophrenia: an open study of 3½ years duration. International Journal of Geriatric Psychiatry. 25(4). 411–418. 16 indexed citations
14.
Ritchie, Craig, Ernest S. Chiu, Susy Harrigan, et al.. (2006). A comparison of the efficacy and safety of olanzapine and risperidone in the treatment of elderly patients with schizophrenia: an open study of six months duration. International Journal of Geriatric Psychiatry. 21(2). 171–179. 20 indexed citations
15.
Villemagne, Victor L., et al.. (2005). Imaginem oblivionis: the prospects of neuroimaging for early detection of Alzheimer's disease. Journal of Clinical Neuroscience. 12(3). 221–230. 39 indexed citations
16.
Mastwyk, Maree, Stephen Macfarlane, Dina LoGiudice, & Karen A. Sullivan. (2003). Why participate in an Alzheimer’s disease clinical trial? Is it of benefit to carers and patients?. Faculty of Health; Institute of Health and Biomedical Innovation. 1 indexed citations
17.
Ritchie, Craig, Susy Harrigan, Kathryn Hall, et al.. (2003). The impact upon extra‐pyramidal side effects, clinical symptoms and quality of life of a switch from conventional to atypical antipsychotics (risperidone or olanzapine) in elderly patients with schizophrenia. International Journal of Geriatric Psychiatry. 18(5). 432–440. 63 indexed citations
18.
Mastwyk, Maree, Stephen Macfarlane, Dina LoGiudice, & Karen A. Sullivan. (2003). Why Participate in an Alzheimer’s Disease Clinical Trial? Is It of Benefit to Carers and Patients?. International Psychogeriatrics. 15(2). 149–156. 11 indexed citations
19.
Mastwyk, Maree, Stephen Macfarlane, Craig Ritchie, Dina LoGiudice, & Karen A. Sullivan. (2002). Carer Impressions of Participation in Alzheimer’s Disease Clinical Trials: What Are Their Hopes? And Is It Worth It?. International Psychogeriatrics. 14(1). 39–45. 1 indexed citations
20.
Yeo, Tet-Kin, Stephen Macfarlane, & Thomas N. Wight. (1992). Characterization of a Chondroitin Sulfate Proteoglycan Synthesized by Monkey Arterial Smooth Muscle Cellsin Vitro. Connective Tissue Research. 27(4). 265–277. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Terry Stedman Breakdown of academic impact, for papers by Lana Dixon Breakdown of academic impact, for papers by Bryan Shapiro Breakdown of academic impact, for papers by Mary Ganguli Breakdown of academic impact, for papers by Patricia A. Marken Breakdown of academic impact, for papers by Maddalena La Montagna Breakdown of academic impact, for papers by Ross Penninkilampi Breakdown of academic impact, for papers by Geetha Ramaswamy Breakdown of academic impact, for papers by Loretta Piccenna Breakdown of academic impact, for papers by Shaw-Ji Chen
Rankless by CCL
2026